PAPER Zetterberg H, Petzold M, Magdalinou N
SEARCH RESULTS
331254 RESULTS
PAPER Ivanova MI, Sievers SA, Guenther EL, Johnson LM, Winkler DD, Galaleldeen A, Sawaya MR, Hart PJ, Eisenberg DS
Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS.
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1) Epub 2013 Dec 16 PubMed: 24344300PAPER Tagashira H, Shioda N, Fukunaga K
WITHDRAWN: A mutation in the chaperone σ1-receptor impairs mitochondrial ATP production in amyotrophic lateral sclerosis.
J Biol Chem. 2014 Jan 7; PubMed: 24338012PAPER Chiò A, Hammond ER, Mora G, Bonito V, Filippini G
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis.
J Neurol Neurosurg Psychiatry. 2013 Dec 13; PubMed: 24336810PAPER Shahidullah M, Le Marchand SJ, Fei H, Zhang J, Pandey UB, Dalva MB, Pasinelli P, Levitan IB
Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS.
J Neurosci. 2013 Dec 11;33(50):19590-8. PubMed: 24336723PAPER Kim HJ, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, Lee VM, Finkbeiner S, Gitler AD, Bonini NM
Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.
Nat Genet. 2014 Feb;46(2):152-60. Epub 2013 Dec 15 PubMed: 24336168PAPER Mioshi E, Caga J, Lillo P, Hsieh S, Ramsey E, Devenney E, Hornberger M, Hodges JR, Kiernan MC
Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival.
Neurology. 2014 Jan 14;82(2):149-55. Epub 2013 Dec 11 PubMed: 24336140PAPER Parisi C, Arisi I, D'Ambrosi N, Storti AE, Brandi R, D'Onofrio M, Volonté C
Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation.
Cell Death Dis. 2013 Dec 12;4:e959. PubMed: 24336079PAPER Ajjuri RR, O'Donnell JM
Novel whole-tissue quantitative assay of nitric oxide levels in Drosophila neuroinflammatory response.
J Vis Exp. 2013 Dec 4;(82):50892. PubMed: 24335747PAPER Nozaki I, Kato-Motozaki Y, Ikeda T, Tagami A, Takahashi K, Ishida C, Komai K
Clinical features in association with neurodegenerative diseases and malignancies.
Eur Neurol. 2014;71(3-4):99-105. Epub 2013 Dec 10 PubMed: 24335185PAPER Shelkovnikova TA, Robinson HK, Troakes C, Ninkina N, Buchman VL
Compromised paraspeckle formation as a pathogenic factor in FUSopathies.
Hum Mol Genet. 2014 May 1;23(9):2298-312. Epub 2013 Dec 11 PubMed: 24334610PAPER Ono Y, Tanaka H, Takata M, Nagahara Y, Noda Y, Tsuruma K, Shimazawa M, Hozumi I, Hara H
SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models.
Neurosci Lett. 2014 Jan 24;559:174-8. Epub 2013 Dec 12 PubMed: 24334165PAPER Navarro-Yepes J, Zavala-Flores L, Anandhan A, Wang F, Skotak M, Chandra N, Li M, Pappa A, Martinez-Fong D, Del Razo LM, Quintanilla-Vega B, Franco R
Antioxidant gene therapy against neuronal cell death.
Pharmacol Ther. 2014 May;142(2):206-30. Epub 2013 Dec 12 PubMed: 24333264PAPER Kiernan MC
ALS and neuromuscular disease: in search of the Holy Grail.
Lancet Neurol. 2014 Jan;13(1):13-4. PubMed: 24331786PAPER Pagnini F, Di Credico C, Gatto R, Fabiani V, Rossi G, Lunetta C, Marconi A, Fossati F, Castelnuovo G, Tagliaferri A, Banfi P, Corbo M, Sansone V, Molinari E, Amadei G
Meditation training for people with amyotrophic lateral sclerosis and their caregivers.
J Altern Complement Med. 2014 Apr;20(4):272-5. Epub 2013 Dec 11 PubMed: 24328393Current Filters
No filters selected